# John B. Buse

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/john-b-buse/

## Facts

| Field | Value |
| --- | --- |
| Citations | 104,809 |
| Field | Diabetes Treatment and Management |
| h-index | 138 |
| i10-index | 491 |
| Last Known Institution | Boston College |
| OpenAlex ID | https://openalex.org/A5040182038 |
| ORCID iD | 0000-0002-9723-3876 |
| Works | 1,049 |

## Researcher papers

Showing 12 of 33.

- [Effects of Intensive Glucose Lowering in Type 2 Diabetes](https://scholariq.org/papers/effects-of-intensive-glucose-lowering-in-type-2-diabetes/)
- [Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes](https://scholariq.org/papers/liraglutide-and-cardiovascular-outcomes-in-type-2-diabetes/)
- [Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)](https://scholariq.org/papers/management-of-hyperglycaemia-in-type-2-diabetes-a-patient-centered-approach/)
- [Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy](https://scholariq.org/papers/medical-management-of-hyperglycemia-in-type-2-diabetes-a-consensus-algorithm-for/)
- [Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)](https://scholariq.org/papers/management-of-hyperglycemia-in-type-2-diabetes-2018-a-consensus-report-by-the/)
- [Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach](https://scholariq.org/papers/management-of-hyperglycemia-in-type-2-diabetes-a-patient-centered-approach/)
- [Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes](https://scholariq.org/papers/management-of-hyperglycemia-in-type-2-diabetes-2015-a-patient-centered-approach/)
- [Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes](https://scholariq.org/papers/effect-of-sitagliptin-on-cardiovascular-outcomes-in-type-2-diabetes/)
- [The Metabolic Syndrome: Time for a Critical Appraisal](https://scholariq.org/papers/the-metabolic-syndrome-time-for-a-critical-appraisal/)
- [Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes](https://scholariq.org/papers/effects-of-once-weekly-exenatide-on-cardiovascular-outcomes-in-type-2-diabetes/)
- [Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)](https://scholariq.org/papers/management-of-hyperglycemia-in-type-2-diabetes-2022-a-consensus-report-by-the/)
- [Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)](https://scholariq.org/papers/liraglutide-once-a-day-versus-exenatide-twice-a-day-for-type-2-diabetes-a-26/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)

## Researcher university

- [Boston College](https://scholariq.org/institutions/boston-college/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.